Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 26.90% vs 32.72% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 103.86% vs 6.92% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 19.62% vs 17.92% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 160.87% vs 552.66% in Mar 2024
Compare Profit and Loss Results of Niva Bupa Health
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,324.00
10,722.00
-5,398.00
-50.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,324.00
10,722.00
-5,398.00
-50.35%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
663.00
637.00
26.00
4.08%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
0.00
0.00
0.00
0%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-62.00
0.00
-62.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,163.00
10,614.00
-5,451.00
-51.36%
Operating Profit (PBDIT) excl Other Income
160.00
108.00
52.00
48.15%
Other Income
205.00
101.00
104.00
102.97%
Operating Profit (PBDIT)
366.00
210.00
156.00
74.29%
Interest
127.00
16.00
111.00
693.75%
Profit before Depriciation and Tax
238.00
193.00
45.00
23.32%
Depreciation
24.00
21.00
3.00
14.29%
Profit Before Taxation & Exceptional Items
214.00
172.00
42.00
24.42%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
213.00
128.00
85.00
66.41%
Provision for Tax
0.00
11.00
-11.00
-100.00%
Profit After Tax
213.00
116.00
97.00
83.62%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
343.00
-343.00
-100.00%
Profit Available for appropriations
213.00
460.00
-247.00
-53.70%
Appropriations
213.00
460.00
-247.00
-53.70%
Equity Dividend (%)
0%
4%
-4.00
Earnings Per Share
1.22
1.23
-0.01
-0.81%
Profit And Loss - Net Sales
Net Sales 5,324.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.90% vs 32.72% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.64 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 103.86% vs 6.92% in Mar 2024
Profit And Loss - Interest
Interest 127.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.62% vs 17.92% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 213.52 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 160.87% vs 552.66% in Mar 2024






